http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108383839-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-10
filingDate 2018-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2019-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108383839-B
titleOfInvention 1,5- azaspiro [2,4] heptane Alkaloid and application thereof
abstract The invention discloses the structures and application thereof of six kinds of new structural 1,5- azaspiro [2,4] heptane Alkaloids.The present invention is to prepare 1,5- azaspiro [2,4] heptane Alkaloid by intramolecular Alder alkene reaction using vinyl azido compound as raw material.The inhibiting effect that 1,5- azaspiro [2,4] heptane class alkaloid moiety compound is proliferated human cervical carcinoma cell is determined with mtt assay, as the result is shown the potential anti-tumor activities of 1,5- azaspiro [2,4] heptane Alkaloids.
priorityDate 2018-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3654305-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450418934
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393352
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21226428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393641
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419568479
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394734
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394677
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419508646
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447941571
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID43226
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414881260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17038
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8900
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74498
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558802
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393789
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455824109
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17904787

Total number of triples: 44.